Q4
19.8.2024 14:01:31 CEST | Business Wire | Press release
Q4 Inc. (“Q4” or “the company”), the IR Ops Platform, today announced it is a winner in the 2024 International Business Awards®. Honored for its “effectiveness in supporting client needs,” the company’s Web Content Services (WCS) team earned a bronze Stevie® Award for “Customer Service Team of the Year” — a category that spanned across industries — underscoring Q4’s commitment to delivering outstanding customer experiences.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240819909828/en/
IBA Bronze Stevie Winner Badge (Graphic: Business Wire)
This is the second year in a row Q4 has been honored in the International Business Awards.
Considered “the Olympics for the workplace,” the International Business Awards (IBAs) are the world’s premier business awards program. All individuals and organizations worldwide – public and private, for-profit and non-profit, large and small — are eligible to submit nominations. The 2024 IBAs received entries from organizations in 62 nations and territories, with more than 3,600 nominations submitted.
Here’s what the judges had to say about Q4’s WCS team:
- “Their achievements reflect exceptional efficiency, accuracy, and client satisfaction.”
- “The team’s ability to handle client requests efficiently, maintain high accuracy, and achieve record CSAT scores highlights their effectiveness in supporting client needs.”
- “Q4’s core company values shine through in the way this team operates.”
- Q4’s WCS team shows “exceptional performance in customer service through impressive metrics, continuous improvement, and a commitment to customer satisfaction.”
- “The WCS team at Q4 has demonstrated outstanding performance.”
“IROs and their teams have a lot on their plates, and we want to alleviate that burden through our AI-driven IR Ops Platform,” said Darrell Heaps, Founder and CEO of Q4. “This recognition from the International Business Awards shows how our amazing Web Content Services team does just that. It also highlights the high-impact results our customers achieve — using Q4 to build investor relationships and make strategic decisions. As we continue to chart a bold, new path for investor relations, we’re committed to innovation that helps IR teams realize remarkable outcomes and frees up their time to focus on what matters: strategy, relationships, and driving premium valuations for their companies.”
Q4: A single, powerful platform for investor relations
Public companies today strive to maintain up-to-date, secure and compliant investor relations websites — so they can demonstrate what they do, attract investors, and motivate them to take action. Q4’s technology makes it easy for some of the world’s biggest brands — McDonald’s, Walmart, Visa, Netflix and many more — to create and manage IR websites that drive results, accelerate website updates (publishing changes within minutes, and 16 times faster than with other tools), streamline earnings management, and tap into real-time analytics on investor behavior. With decades of website design and IR experience, Q4’s award-winning WCS team provides further assistance with website development and change requests, as well as Q4 Platform support.
Websites are just one component of Q4’s holistic IR Ops Platform, an unprecedented and unified system for attracting investors, managing relationships and staying abreast of the market’s pulse. Rather than grapple with disparate and disconnected tools, IR leaders and their companies can access everything they need from a single place: using Q4 for IR websites, virtual events, an IR CRM, surveillance, engagement analytics and more, including secure AI for IR.
Q4’s win in the International Business Awards comes on the heels of other recent milestones and momentum for the company. Q4 has powered more than 18 million investor interactions and hosts 4,400 events annually — with 530,000+ investors connecting to events via the Q4 Platform each month. Named “Best Tech-Driven Capital Markets Platform” by Global Brands Magazine, Q4 serves more than 2,600 global clients, including half of the S&P 500.
About Q4 Inc.
Q4 Inc. is the first IR Ops Platform with the world’s largest set of proprietary investor data, purpose-built to remove obstacles between public companies and their investors. Q4 gives investor relations leaders and their teams the tools to attract, manage, and understand investors — all in one place. The AI-enabled Q4 IR Ops Platform boasts applications for website and event management, engagement analytics, and earnings lifecycle management, including AI Earnings Co-Pilot to generate draft scripts based on historical data, and AI earnings call summaries to understand peer sentiment. The Platform also includes a streamlined investor CRM and shareholder intelligence with enhanced metrics to elevate investor targeting strategies. Q4 delivers the data, insights, and workflows that give IR teams the power to focus on what really matters: strategy, relationships, and driving premium valuations for their companies.
The company is a trusted partner to more than 2,600 public companies globally, including many of the most respected brands in the world, and maintains an award winning culture where team members grow and thrive.
Q4 is headquartered in Toronto, with offices in London and Copenhagen. Learn more at www.q4inc.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240819909828/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Alnylam Presents New Data at ESC Congress 2026 Reinforcing Strength in RNAi-Powered TTR Silencing Across ATTR-CM Patient Populations and Treatment Settings30.8.2026 14:23:00 CEST | Press release
–Late-Breaking Prespecified Subgroup Analysis of HELIOS-B Demonstrates that Vutrisiran Provided Consistent Clinical Benefit Across All-Cause Mortality and Recurrent Cardiovascular Events in Patients With or Without Tafamidis Use at Baseline ––Additional Post Hoc Analyses Highlight Positive Impact of Vutrisiran in Addressing the Multisystemic Manifestations of ATTR-CM ––Pooled Analysis Across Four Positive Phase 3 Studies of Vutrisiran and Patisiran Shows Consistent Treatment Effect Across Sexes ––New Subgroup Analysis from KARDIA-3 Phase 2 Study of Zilebesiran Highlights Potential to Provide Enhanced Blood Pressure Control – Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced new data at the European Society of Cardiology (ESC) Congress 2026 demonstrating the strength of RNAi-powered silencing for cardiovascular disease. The findings further reinforce the clinical profile of AMVUTTRA® (vutrisiran) across transthyretin amyloidosis (ATTR)
New Auction Record Set as Falcon Sells for AED 1.5 Million at ADIHEX 202629.8.2026 23:54:00 CEST | Press release
Qarmousha Pure Ultra White falcon sells for AED 1.5 million at the Abu Dhabi International Hunting and Equestrian Exhibition 2026 (ADIHEX) falcon auction Under the patronage of His Highness Sheikh Hamdan bin Zayed Al Nahyan, Ruler’s Representative in Al Dhafra Region and Chairman of the Emirates Falconers’ Club, the fifth auction held as part of the 23rd edition of the Abu Dhabi International Hunting and Equestrian Exhibition (ADIHEX) 2026 attracted remarkable turnout, culminating in the sale of a Qarmousha Pure Ultra White falcon for AED 1.5 million (USD 408,000). The sale marks the highest price achieved at any auction during this year’s edition of the exhibition. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260829032621/en/ Qarmousha Pure Ultra White (Photo: AETOSWire) This forms part of the largest auction programme in the exhibition’s history, held under the theme “A Legacy of Pride,” organised by ADNEC Group, a Modon
Takeda Receives U.S. FDA Approval of MIMRYLO™ (rusfertide), Marking a Potential Shift in the Treatment Paradigm for Polycythemia Vera29.8.2026 00:40:00 CEST | Press release
MIMRYLO, a First-in-Class Medicine with a Unique Mechanism of Action, is Approved for the Treatment of Erythrocytosis in Adults with Polycythemia Vera (PV)MIMRYLO Has Been Shown to Maintain Hematocrit Control, the Primary Treatment Goal in PV, as Well as Reduce Phlebotomy Burden and Improve FatigueApproval Supported by Phase 3 VERIFY Results Showing 76.9% of Patients Achieved Clinical Response During Weeks 20-32 Takeda (TSE:4502/NYSE:TAK)announced U.S. Food and Drug Administration (FDA) approval of the New Drug Application (NDA)* for MIMRYLO™ (rusfertide) for the treatment of erythrocytosis in adults with polycythemia vera (PV), a blood cancer. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260824773270/en/ MIMRYLO Logo MIMRYLO is a first-in-class hepcidin mimetic designed to regulate iron distribution in the body and red blood cell overproduction to control hematocrit levels, which is the ratio of red blood cells to the tot
Rigaku and Tohoku University Establish a New Research Institute for X-Ray Metrology28.8.2026 16:00:00 CEST | Press release
Rigaku Corporation, a group company of Rigaku Holdings and a global solutions partner for X-ray analytical systems (Head Office: Akishima, Tokyo; President and CEO: Jun Kawakami; “Rigaku”), and Tohoku University (Sendai, Miyagi; President: Teiji Tominaga; “Tohoku University”) have established the Rigaku-Tohoku University Co-Creation Research Institute for X-ray Metrology: Beyond The Limits (the “Institute”) at Tohoku University on August 1, 2026. The Institute will advance X-ray metrology technology, develop new metrology methods, and foster the next generation of researchers through an initial three-year collaboration, with the possibility of extension based on its achievements. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260828688510/en/ Inside the Institute As semiconductors become smaller, more multilayered, and incorporate a wider range of materials, manufacturing processes are becoming increasingly complex. X-ray me
BLK: Portfolio Company of Enry’s Island S.p.A., Lists on Euronext Dublin28.8.2026 15:34:00 CEST | Press release
Enry’s Island S.p.A. (WBAG:EIOS), an international venture builder with headquarters in the Tremiti Islands and the Metaverse, announces that BLK Global PLC, one of the portfolio companies within its ecosystem, has successfully completed its admission to trading on Euronext Access Dublin. Trading in the company’s shares commenced on Friday, July 31, 2026, under ticker BLKX and ISIN GB00BPSKS130. BLK was one of the thousands of applications received by Enry’s Island which, following an assessment process based on the Enry’s Model, was selected for a one-year incubation and acceleration programme. The programme supported the company through its subsequent growth stages, ultimately leading to its current stock market listing. Alessandro Pacciana, Investor Relations Manager of Enry’s Island S.p.A., said: “BLK’s listing is the second stock market listing in two years among Enry’s Island’s portfolio companies, while Enry’s Island itself is the world’s first listed venture builder. We are pro
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
